Glofitamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Glofitamab Usage And Synthesis

Description

Glofitamab is part of Genentech's industry-leading CD20xCD3 bispecific antibody development program, which aims to address the diverse needs and preferences of people with blood cancers.

Uses

Glofitamab is a T-cell binding bispecific antibody designed to target CD20 on the surface of B cells and CD3 on the surface of T cells.

Glofitamab(2229047-91-8)Related Product Information

• Urelumab
• varlilumab
• Eptinezumab
• Atezolizumab
• Obinutuzumab
• Sutimlimab
• Utomilumab
• Nesvacumab
• Odronextamab
• Rituximab